查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年光动态治疗 (PDT) 市场预测：按细分市场和地区分類的全球分析
市场调查报告书
商品编码
1358961

2030 年光动态治疗 (PDT) 市场预测：按细分市场和地区分類的全球分析

Photodynamic Therapy Market Forecasts to 2030 - Global Analysis By Product (Photosensitizer Drugs, Photodynamic Therapy Devices and Other Products), Indication, Treatment Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球动态治疗 (PDT) 市场规模为 56 亿美元，预计在预测期内将以 15.5% 的年复合成长率增长，到 2030 年达到 153.6 亿美元。

动态疗法 (PDT) 使用光敏感药物和光的组合来治疗各种医学，包括一些癌症和非癌症疾病。它是一种微创方法，可以靶向并去除异常或恶性细胞，同时对周围健康组织的伤害最小。动态疗法 (PDT) 可用于治疗多种疾病，包括癌症、老龄化黄斑部病变(AMD)、光化性角化症、痤疮和其他皮肤病。

根据世界卫生组织 (WHO) 2022 年 2 月更新的关键事实，癌症是全球头号死亡原因，2020 年将导致约 1,000 万人死亡，约六分之一的死亡。他即将死于癌症。因此，全球患病盛行率不断增加，对光敏剂的需求也预计会增加。

癌症和皮肤病的发生率增加

癌症发生率不断上升，尤其是基底细胞癌和鳞状细胞癌等皮肤恶性，推动了对 PDT 等有效替代疗法的需求。随着世界各地癌症发生率持续上升，PDT 能够靶向癌细胞，同时最大限度地减少对健康组织的伤害，这是关键驱动因素。此外，PDT 作为化疗和标准手术的侵入性较小的治疗方法替代方案而受到关注。随着患者寻求侵入性较小的治疗方法帮助他们更快康復并减少副作用，对 PDT 的需求不断增加。

竞争治疗方法与法规挑战

在某些医疗情况下，PDT 经常与其他治疗方法（例如手术、化疗、放射线治疗和免疫疗法）竞争。这些其他治疗方法的有效性或缺点可能会威胁 PDT 的市场占有率。对于新的光敏药物和 PDT 申请，法规核准过程可能漫长且困难。市场扩张可能会被推迟，获得法规批准的延迟和挑战可能会减少 PDT 的选择范围。由于缺乏保险覆盖范围以及使用 PDT 的环境受到限制，医疗保健专业人员和患者都对选择 PDT 作为治疗方案犹豫不决，这阻碍了市场的成长。但这种情况是有可能发生的。

将最新的影像影像方法与个体化治疗方法相结合

个人化医疗和分子检测的进步使得在设计 PDT 治疗时可以考虑个别患者的特征。此方法提高了治疗效果和患者满意度，并提供了一种将精准医疗纳入PDT治疗的方法。透过改进影像技术，可以更好地观察目标组织，从而提高 PDT 治疗的准确性。萤光成像和分子成像是成像技术最新进展的两个例子，它们可能为更有效的治疗计划和监测提供预测。

高可维护性

这种治疗方法的主要问题之一是动态疗法（PDT）的高成本。 PDT 的费用取决于多种要素，并且费用根据所治疗的疾病、地点和医疗保健提供者而有所不同。 PDT 需要雷射或其他光源来活化光敏剂。这些设备的购买和维护费用昂贵。 PDT 中使用的光敏剂製造成本昂贵，并且可能无法广泛使用，从而阻碍了市场成长。

COVID-19 的影响：

与其他医疗治疗和手术一样，动态疗法 (PDT) 受到了 COVID-19 大大流行的显着影响。然而，自那时以来，对 PDT 市场影响的规模和性质可能已经发生了变化。此次疫情的爆发对医疗保健产业造成了重大破坏。这些中断影响了常用于治疗非危及生命的疾病的 PDT，并可能导致治疗延误。全球供应链的中断可能影响了医疗产品的製造和分销，特别是用于 PDT 的光敏药物。这可能导致获得必要的 PDT 成分的延迟或短缺。

预计光敏剂领域在预测期内将是最大的

动态疗法 (PDT) 是一种使用光活性物质来靶向并消除异常或恶性细胞的医疗程序，其关键组成部分有时被称为光敏剂。这些药物是 PDT 过程的重要组成部分，因为它们在暴露于特定波长的光时可以选择性地杀死目标细胞。充当光敏剂的药物对于 PDT 的有效性至关重要，因为它们可以进行标靶治疗，同时对附近健康组织的伤害较小。成功的治疗效果取决于合适光敏剂的选择和治疗参数的最佳化。

全身PDT领域预计在预测期内年复合成长率最高

在全身动态疗法（PDT）中，光敏剂透过静脉注射，使其在全身和目标细胞中循环。这种方法用于治疗需要广泛或深层嵌入异常细胞的疾病，例如某些癌症。全身 PDT 是治疗传统 PDT 难以治疗的多种医学疾病的一种有前途的方法。即使病变广泛或根深蒂固，治疗也是可能的，而该领域的持续研究正在扩大其用途并改善治疗结果。确切的医学问题和患者的具体情况将决定最佳的治疗方案，无论是传统的还是全身的 PDT。

比最大的地区

北美地区受美国重要公司的存在、癌症治疗新生技药品需求不断增长、动态疗法（PDT）采用率高以及市场参与者发布新产品的推动，预计将占据最大市场占有率。此外，美国食品药物管理局(FDA)产品核可增加，动态动态病 (PDT) 的治疗和管理激增，以及动态疗法 (PDT) 的可用性增加。

复合年复合成长率最高的地区：

由于该地区癌症患者和其他可透过 PDT 治疗的疾病数量不断增加，预计亚太地区在预测期内的年复合成长率最高。 PDT 作为一种治疗选择越来越受欢迎，尤其是在日本、韩国、中国和印度等国家。随着人口老化，老龄化相关性黄斑部病变（AMD）和某些皮肤恶性等与老龄化相关的疾病在亚太地区的一些高龄化变得越来越常见。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 用途分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球动态治疗 (PDT) 市场：按产品

  • 光敏剂
    • 氨基乙酰丙酸
    • 氯
    • 卟啉衍生物
    • 血卟啉衍生物
    • 酞菁
    • 其他光敏剂
  • 动态治疗仪
    • 二极体雷射
    • 免洗光纤光纤传输装置
  • 其他产品

第6章全球动态治疗（PDT）市场：依适应症分类

  • 皮肤病
  • 眼科
  • 感染疾病
  • 癌症
  • 其他适应症

第7章全球动态疗法（PDT）市场：依治疗类型

  • 局部PDT
  • 全身光动力疗法
  • 表面光动力治疗

第8章全球动态治疗（PDT）市场：依用途

  • 肿瘤学
  • 妇科
  • 消化内科
  • 泌尿系统
  • 皮肤科
  • 其他用途

第9章全球动态治疗 (PDT) 市场：按最终用户分类

  • 医院
  • 美容皮肤科诊所
  • 门诊手术中心
  • 研究机构
  • 其他最终用户

第10章全球动态治疗（PDT）市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第11章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第12章公司简介

  • Asieris Meditech Co., Ltd.
  • Bausch Health Companies Inc.
  • Biofrontera AG
  • Biolase, Inc
  • Biolitec AG
  • Boston Scientific Corporation
  • Candela Corporation
  • DUSA Pharmaceuticals
  • Galderma SA
  • Lumibird（Quantel Medical）
  • Modulight, Inc.
  • PDT Pharmaceuticals
  • Photocure ASA
  • Photothera
  • Quest PharmaTech Inc.
  • Soligenix
  • Sun Pharmaceutical Industries Limited
  • Theralase Technologies Inc.
Product Code: SMRC23833

According to Stratistics MRC, the Global Photodynamic Therapy Market is accounted for $5.60 billion in 2023 and is expected to reach $15.36 billion by 2030 growing at a CAGR of 15.5% during the forecast period. In order to treat a variety of medical illnesses, including some forms of cancer and other non-cancerous conditions, photodynamic therapy (PDT) employs a combination of photosensitive medications and light. With the least amount of harm to the surrounding healthy tissue, it is a minimally invasive method that can be used to target and eliminate aberrant or malignant cells. Photodynamic therapy can be used to treat various conditions, including cancer, age-related macular degeneration (AMD), actinic keratosis, acne and other skin conditions

According to World Health Organization (WHO), Key facts updated in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Thus, the increasing prevalence of cancer cases across the globe is expected to rise the demand for photosensitizer drugs

Market Dynamics:

Driver:

Rising rates of cancer and skin disorders

The demand for efficient treatment alternatives like PDT is driven by the increased incidence of cancer, particularly skin malignancies like basal cell carcinoma and squamous cell carcinoma. PDT's capacity to target cancer cells while limiting harm to healthy tissue becomes an important driver as cancer rates around the world continue to climb. In addition, PDT is viewed as a less invasive alternative to chemotherapy and standard surgery. The demand for PDT has grown as patients look for less invasive treatments with speedier recoveries and fewer side effects.

Restraint:

Competing therapeutic approaches and regulatory challenges

Depending on the medical situation, PDT frequently competes with other treatment techniques such surgery, chemotherapy, radiation therapy, and immunotherapy. The efficacy and drawbacks of these other treatments could threaten PDT's market share. For new photosensitive medications or PDT applications, regulatory approval procedures can be drawn-out and difficult. Market expansion might be slowed down and the range of PDT alternatives can be constrained by delays or challenges with obtaining regulatory licenses. Both healthcare professionals and patients may be discouraged from selecting PDT as a therapy option by inadequate insurance coverage or limitations on the circumstances under which PDT is covered which hampers the growth of the market.

Opportunity:

Modern imaging methods combined with personalized treatment methods

Individual patient characteristics may be taken into account while designing PDT treatments thanks to developments in personalized medicine and molecular testing. This method improves treatment results and patient satisfaction and offers a way to include precision medicine into PDT procedures. The accuracy of PDT treatments can be increased by improved imaging technologies that offer greater viewing of the targeted tissues. Fluorescence imaging and molecular imaging are two examples of recent advancements in imaging techniques that may offer prospects for more efficient intervention planning and monitoring thus creating wide range of opportunities for the growth of the market.

Threat:

High maintenance

One major issue with this treatment approach is the expensive expense of photodynamic therapy (PDT). PDT is expensive due to a number of factors, and these costs can change based on the illness being treated, the location, and the healthcare provider. Lasers or other types of light sources are needed for PDT in order to activate the photosensitizer. These gadgets can be expensive to buy and maintain. The photosensitive medications used in PDT can be costly to produce and may not be widely available thereby impedes the growth of the market.

COVID-19 Impact:

Photodynamic Therapy (PDT), like other medical treatments and procedures, was significantly impacted by the COVID-19 pandemic. But since then, it's possible that the size and character of the influence on the PDT market have changed. The epidemic caused significant disruptions in the healthcare industry. These interruptions may have had an impact on PDT, which is frequently used to treat non-life-threatening diseases, causing delays in therapy. Disruptions in global supply chains may have had an impact on the manufacture and distribution of medical products, especially photosensitive medications used in PDT. This might have caused delays or shortages in getting necessary PDT components.

The photosensitizer drugs segment is expected to be the largest during the forecast period

The photosensitizer drugs segment is estimated to have a lucrative growth, as these are a crucial element of Photodynamic Therapy (PDT), a medical procedure that employs light-activated substances to target and eliminate aberrant or malignant cells, are photosensitizer medications, sometimes referred to as simply photosensitizers. These medications are an essential component of the PDT procedure because they allow for the selective death of target cells when they are subjected to particular light wavelengths. Drugs that act as photosensitizers are essential to the efficacy of PDT because they allow for targeted treatment with little harm to nearby healthy tissue. Achieving successful therapeutic results depends on choosing the right photosensitizer and optimizing the therapy parameters.

The systemic PDT segment is expected to have the highest CAGR during the forecast period

The systemic PDT segment is anticipated to witness the highest CAGR growth during the forecast period, as photosensitizer medication is injected intravenously in systemic photodynamic therapy (PDT), which allows it to circulate throughout the body and target cells systemically. This method is used to treat diseases like some forms of cancer that require extensive or deeply embedded aberrant cells. A promising method of treating some medical diseases that are difficult to target with regular PDT is systemic PDT. Widespread or deeply positioned lesions can be treated, and continuous research in the field is expanding its uses and enhancing its results. The precise medical problem and the patient's unique circumstances will determine the best course of treatment, whether it is traditional PDT or systemic PDT.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the presence of significant companies in the United States, rising demand for new biologics for the treatment of cancer, a high rate of adoption of photodynamic therapy, and new product releases by market players. Moreover, as a result of an increase in product approvals by the US Food and Drug Administration, a surge in the use of photodynamic therapy for the treatment and management of actinic keratosis, and an increase in the number of cosmetologists offering photodynamic therapy.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to cancer cases and other illnesses that can be treated with PDT are on the rise in the Asia-Pacific region. PDT has been increasingly popular as a therapeutic option, particularly in nations like Japan, South Korea, China, and India. Age-related illnesses like age-related macular degeneration (AMD) and specific skin malignancies are more common due to the aging population in several Asia Pacific nations.

Key players in the market:

Some of the key players profiled in the Photodynamic Therapy Market include: Asieris Meditech Co., Ltd., Bausch Health Companies Inc., Biofrontera AG, Biolase, Inc, Biolitec AG, Boston Scientific Corporation, Candela Corporation , DUSA Pharmaceuticals, Galderma S.A., Lumibird (Quantel Medical), Modulight, Inc., PDT Pharmaceuticals, Photocure ASA, Photothera, Quest PharmaTech Inc., Soligenix, Sun Pharmaceutical Industries Limited and Theralase Technologies Inc.

Key Developments:

In May 2023, Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer. Asieris Pharmaceuticals will obtain exclusive global rights to UroViu's patented technology of portable single-use cystoscope in the field of fluorescent imaging.

In August 2022, Asieris Pharmaceuticals announced its multinational Phase III Clinical Trial of Cevira(APRICITY), novel non-surgical treatment of cervical high-grade squamous intraepithelial lesions (HSIL), has completed enrollment. Cevira is a breakthrough photodynamic drug-device combination product, based on the accumulation of a photosensitizer in the target cells.

Products Covered:

  • Photosensitizer Drugs
  • Photodynamic Therapy Devices
  • Other Products

Indications Covered:

  • Dermatological Conditions
  • Ophthalmology
  • Infectious Diseases
  • Cancer
  • Other Indications

Treatment Types Covered:

  • Local PDT
  • Systemic PDT
  • Topical PDT

Applications Covered:

  • Oncology
  • Gynecology
  • Gastroenterology
  • Urology
  • Dermatology
  • Other Applications

End Users Covered:

  • Hospitals
  • Cosmetic and Dermatology Clinics
  • Ambulatory Surgical Centers
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Photodynamic Therapy Market, By Product

  • 5.1 Introduction
  • 5.2 Photosensitizer Drugs
    • 5.2.1 Aminolevulinic Acid
    • 5.2.2 Chlorines
    • 5.2.3 Porphyrin Derivatives
    • 5.2.4 Hematoporphyrin Derivative
    • 5.2.5 Phthalocyanines
    • 5.2.6 Other Photosensitizer Drugs
  • 5.3 Photodynamic Therapy Devices
    • 5.3.1 Diode Lasers
    • 5.3.2 Disposable Fiber Optic Light Delivery Devices
  • 5.4 Other Products

6 Global Photodynamic Therapy Market, By Indication

  • 6.1 Introduction
  • 6.2 Dermatological Conditions
  • 6.3 Ophthalmology
  • 6.4 Infectious Diseases
  • 6.5 Cancer
  • 6.6 Other Indications

7 Global Photodynamic Therapy Market, By Treatment Type

  • 7.1 Introduction
  • 7.2 Local PDT
  • 7.3 Systemic PDT
  • 7.4 Topical PDT

8 Global Photodynamic Therapy Market, By Application

  • 8.1 Introduction
  • 8.2 Oncology
  • 8.3 Gynecology
  • 8.4 Gastroenterology
  • 8.5 Urology
  • 8.6 Dermatology
  • 8.7 Other Applications

9 Global Photodynamic Therapy Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Cosmetic and Dermatology Clinics
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Research Institutes
  • 9.6 Other End Users

10 Global Photodynamic Therapy Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Asieris Meditech Co., Ltd.
  • 12.2 Bausch Health Companies Inc.
  • 12.3 Biofrontera AG
  • 12.4 Biolase, Inc
  • 12.5 Biolitec AG
  • 12.6 Boston Scientific Corporation
  • 12.7 Candela Corporation
  • 12.8 DUSA Pharmaceuticals
  • 12.9 Galderma S.A.
  • 12.10 Lumibird (Quantel Medical)
  • 12.11 Modulight, Inc.
  • 12.12 PDT Pharmaceuticals
  • 12.13 Photocure ASA
  • 12.14 Photothera
  • 12.15 Quest PharmaTech Inc.
  • 12.16 Soligenix
  • 12.17 Sun Pharmaceutical Industries Limited
  • 12.18 Theralase Technologies Inc.

List of Tables

  • Table 1 Global Photodynamic Therapy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Photodynamic Therapy Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Photodynamic Therapy Market Outlook, By Photosensitizer Drugs (2021-2030) ($MN)
  • Table 4 Global Photodynamic Therapy Market Outlook, By Aminolevulinic Acid (2021-2030) ($MN)
  • Table 5 Global Photodynamic Therapy Market Outlook, By Chlorines (2021-2030) ($MN)
  • Table 6 Global Photodynamic Therapy Market Outlook, By Porphyrin Derivatives (2021-2030) ($MN)
  • Table 7 Global Photodynamic Therapy Market Outlook, By Hematoporphyrin Derivative (2021-2030) ($MN)
  • Table 8 Global Photodynamic Therapy Market Outlook, By Phthalocyanines (2021-2030) ($MN)
  • Table 9 Global Photodynamic Therapy Market Outlook, By Other Photosensitizer Drugs (2021-2030) ($MN)
  • Table 10 Global Photodynamic Therapy Market Outlook, By Photodynamic Therapy Devices (2021-2030) ($MN)
  • Table 11 Global Photodynamic Therapy Market Outlook, By Diode Lasers (2021-2030) ($MN)
  • Table 12 Global Photodynamic Therapy Market Outlook, By Disposable Fiber Optic Light Delivery Devices (2021-2030) ($MN)
  • Table 13 Global Photodynamic Therapy Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 14 Global Photodynamic Therapy Market Outlook, By Indication (2021-2030) ($MN)
  • Table 15 Global Photodynamic Therapy Market Outlook, By Dermatological Conditions (2021-2030) ($MN)
  • Table 16 Global Photodynamic Therapy Market Outlook, By Ophthalmology (2021-2030) ($MN)
  • Table 17 Global Photodynamic Therapy Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 18 Global Photodynamic Therapy Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 19 Global Photodynamic Therapy Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 20 Global Photodynamic Therapy Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 21 Global Photodynamic Therapy Market Outlook, By Local PDT (2021-2030) ($MN)
  • Table 22 Global Photodynamic Therapy Market Outlook, By Systemic PDT (2021-2030) ($MN)
  • Table 23 Global Photodynamic Therapy Market Outlook, By Topical PDT (2021-2030) ($MN)
  • Table 24 Global Photodynamic Therapy Market Outlook, By Application (2021-2030) ($MN)
  • Table 25 Global Photodynamic Therapy Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 26 Global Photodynamic Therapy Market Outlook, By Gynecology (2021-2030) ($MN)
  • Table 27 Global Photodynamic Therapy Market Outlook, By Gastroenterology (2021-2030) ($MN)
  • Table 28 Global Photodynamic Therapy Market Outlook, By Urology (2021-2030) ($MN)
  • Table 29 Global Photodynamic Therapy Market Outlook, By Dermatology (2021-2030) ($MN)
  • Table 30 Global Photodynamic Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 31 Global Photodynamic Therapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 32 Global Photodynamic Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 33 Global Photodynamic Therapy Market Outlook, By Cosmetic and Dermatology Clinics (2021-2030) ($MN)
  • Table 34 Global Photodynamic Therapy Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 35 Global Photodynamic Therapy Market Outlook, By Research Institutes (2021-2030) ($MN)
  • Table 36 Global Photodynamic Therapy Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.